National Academies Press: OpenBook

Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction (2001)

Chapter: Appendix A: Presentations and Submissions

Get This Book
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
« Previous: 16 Other Health Effects
Page 581 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel

Appendixes

Page 582 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel
This page in the original is blank.
Page 583 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel

A
Presentations and Submissions

The committee would like to thank the following people who shared their expertise.

PRESENTATIONS

December 15, 1999, Washington, D.C.

Presentation of the Charge to the Institute of Medicine Committee

Mitch Zeller, Food and Drug Administration (current affiliation, American Legacy Foundation

Bern Schwetz, Food and Drug Administration

March 2, 2000, Washington, D.C.

Harm Reduction and Lessons Learned: Historical Perspective and Policy Advice

John Slade, University of Medicine and Dentistry at New Jersey School of Public Health

Harm Reduction and Lessons Learned: Low Tar and Nicotine Story

Don Shopland, National Cancer Institute

Tobacco Toxicology Review: Emphasis on Carcinogenesis

Steve Hecht, University of Minnesota

Exposure Assays

David Ashley, Centers for Disease Control and Prevention

Nicotine Pharmacology and Toxicology

Neal Benowitz, University of California, San Francisco

Page 584 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel
April 25, 2000, Washington, D.C.

Risk Perception and Decision Making

Paul Slovic, Decision Research, University of Oregon

Epidemiology of Low-Tar Cigarettes

David Burns, University of California, San Diego

Clinical Trial Design Considerations

Jack Henningfield, Pinney Associates, Johns Hopkins School of Medicine

Janine Pillitteri, Pinney Associates

John Hughes, University of Vermont

Clinical Indicators of Chronic Obstructive Pulmonary Disease

Steve Rennard, University of Nebraska

Physical and Chemical Characteristics of Tobacco Smoke

Robert Phalen, University of California, Irvine

State of Massachusetts Regulation of Tobacco Products

Gregory Connolly, Massachusetts Department of Public Health

Michael Borgerding, R.J. Reynolds Tobacco Company

CONTRIBUTIONS

Thoughtful contributions were also provided by the following:

Industry Representatives

Brown and Williamson Tobacco Company

Scott Appleton

Sharon Boyse

Rufus Honeycutt

Tilford Riehl

Lorillard Tobacco Company

Christopher Coggins and colleagues

Chuck Gaworski

J.Dan Heck

Philip Morris Tobacco Company

Richard A.Carchman

Bruce D.Davies

Hans-Juergen Haussmann

Robin D.Kinser

Donald E.Leyden

George J.Patskan

Richard P.Solana

Anthony R.Ticker

Page 585 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel

R.J. Reynolds Tobacco Company

Michael Borgerding

J.Donald deBethizy

David Doolittle

David Iauco

Arnold T.Mosberg

Seth Moskowitz

John H.Robinson

Robert L.Suber

James E.Swauger

Star Scientific, Inc.

Scott D.Ballin

Jerome H.Jaffe

Paul L.Perito

GlaxoWellcome Pharmacutical

Brenda Jamerson

Pharmacia Corporation

Mikael Franzon

Vibeke Kronborg

Smith Kline Beecham

Individuals

Gregory Dalack, VA Ann Arbor Healthcare System

Karl Fagerstrom, Fagerstrom Consulting

Nigel Gray, European Institute of Oncology

Jack Henningfield, Pinney Associates

Thomas Houston, American Medical Association

John Hughes, University of Vermont

Anne Kirchner, Food and Drug Administration

Robert Nilsson, National Chemicals Inspectorate, Sweden

Brad Radu, University of Alabama

Elsy-Britt Schildt, University Hospital, Sweden

Saul Shiffman, University of Pittsburgh and Pinney Associates

John Slade, University of Medicine and Dentistry at New Jersey School of Public Health

Steven Stellman, American Health Foundation

David Sweanor, Smoking and Health Action Foundation, Canada

Puzant Torigian

Dennis Ole Wik

Judy Wilkenfeld, Campaign for Tobacco Free Kids

Richard Windsor, University of Alabama

Page 581 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel
Page 581
Page 582 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel
Page 582
Page 583 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel
Page 583
Page 584 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel
Page 584
Page 585 Cite
Suggested Citation:"Appendix A: Presentations and Submissions." Institute of Medicine. 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press. doi: 10.17226/10029.
×
Save
Cancel
Page 585
Next: Appendix B: Committee Biographical Sketches »
Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction Get This Book
×
Buy Hardback | $75.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Despite overwhelming evidence of tobacco's harmful effects and pressure from anti-smoking advocates, current surveys show that about one-quarter of all adults in the United States are smokers. This audience is the target for a wave of tobacco products and pharmaceuticals that claim to preserve tobacco pleasure while reducing its toxic effects.

Clearing the Smoke addresses the problems in evaluating whether such products actually do reduce the health risks of tobacco use. Within the context of regulating such products, the committee explores key questions:

  • Does the use of such products decrease exposure to harmful substances in tobacco?
  • Is decreased exposure associated with decreased harm to health?
  • Are there surrogate indicators of harm that could be measured quickly enough for regulation of these products?
  • What are the public health implications?

This book looks at the types of products that could reduce harm and reviews the available evidence for their impact on various forms of cancer and other major ailments. It also recommends approaches to governing these products and tracking their public health effects.

With an attitude of healthy skepticism, Clearing the Smoke will be important to health policy makers, public health officials, medical practitioners, manufacturers and marketers of "reduced-harm" tobacco products, and anyone trying to sort through product claims.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!